In this report, our team research the global 133 market by type, application, region and manufacturer 2013-2018 and forcast 2019-2024. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
454 Life Sciences Corporation
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Macrogen
Oxford Nanopore Technologies
Bio-Rad Laboratories
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Other Technologies
By Application, the market can be split into
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
By Regions, this report covers (we can add the regions/countries as you want)
If you have any special requirements, please let us know and we will offer you the report as you want.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Next Generation Sequencing Market, By Technology
7.1. Next Generation Sequencing Market, By Technology Type, 2020-2027
7.1.1. Whole Genome Sequencing
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Whole Exome Sequencing
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Targeted Sequencing & Resequencing
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Next Generation Sequencing Market, By Application
8.1. Next Generation Sequencing Market, By Application, 2020-2027
8.1.1. Oncology
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Clinical Investigation
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Reproductive Health
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. HLA Typing/Immune System Monitoring
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Metagenomics, Epidemiology & Drug Development
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Agrigenomics & Forensics
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Consumer Genomics
8.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Next Generation Sequencing Market, By Workflow
9.1. Next Generation Sequencing Market, By Filling Material, 2020-2027
9.1.1. Pre-sequencing
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. NGS Data Analysis
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Next Generation Sequencing Market, By End-use
10.1. Next Generation Sequencing Market, By End-use, 2020-2027
10.1.1. Academic Research
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Clinical Research
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Hospitals & Clinics
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Pharma & Biotech Entities
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Other Users
10.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Next Generation Sequencing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.2. Market Revenue and Forecast, By Application (2016-2027)
11.1.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.1.4. Market Revenue and Forecast, By End-use(2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.1.5.4. Market Revenue and Forecast, By End-use(2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.1.6.4. Market Revenue and Forecast, By End-use(2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.2.4. Market Revenue and Forecast, By End-use(2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.2.5.4. Market Revenue and Forecast, By End-use(2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.2.6.4. Market Revenue and Forecast, By End-use(2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.2.7.4. Market Revenue and Forecast, By End-use(2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.2.8.4. Market Revenue and Forecast, By End-use(2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.3.4. Market Revenue and Forecast, By End-use(2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.3.5.4. Market Revenue and Forecast, By End-use(2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.3.6.4. Market Revenue and Forecast, By End-use(2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.3.7.4. Market Revenue and Forecast, By End-use(2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.3.8.4. Market Revenue and Forecast, By End-use(2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.4.4. Market Revenue and Forecast, By End-use(2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.4.5.4. Market Revenue and Forecast, By End-use(2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.4.6.4. Market Revenue and Forecast, By End-use(2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.4.7.4. Market Revenue and Forecast, By End-use(2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.4.8.4. Market Revenue and Forecast, By End-use(2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.5.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.5.4. Market Revenue and Forecast, By End-use(2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.5.5.4. Market Revenue and Forecast, By End-use(2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Workflow(2016-2027)
11.5.6.4. Market Revenue and Forecast, By End-use(2016-2027)
Chapter 12. Company Profiles
12.1. Illumina Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. F Hoffman-La Roche Ltd.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. QIAGEN
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Thermo Fisher Scientific Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. BGI
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms